Open Access

[Corrigendum] DR2 blocker thioridazine: A promising drug for ovarian cancer therapy

  • Authors:
    • Min Yong
    • Tinghe Yu
    • Si Tian
    • Shuaibin Liu
    • Jiao Xu
    • Jianguo Hu
    • Lina Hu
  • View Affiliations

  • Published online on: January 9, 2020     https://doi.org/10.3892/ol.2020.11285
  • Pages: 2072-2072
  • Copyright : © Yong et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

Subsequently to the publication of the above article, the authors have realized that Figs. 1 and 2 contained incorrect GAPDH control bands; in particular, the same GADPH bands had erroneously been included twice in Fig. 2 for experiments that involved two different cell lines. These GAPDH bands were included inadertently in this pair of figures owing to a mislabelling of the original data files. The corrected versions of Figs. 1 and 2, as they should have appeared in the Journal, are shown opposite. All the authors agree to this Corrigendum. Note that the revisions made to these figures do not adversely affect the results reported in the paper, or the conclusions stated therein. The authors regret that these errors were not noticed prior to the publication of this article, and offer their apologies to the Editor and to the readers of the Journal. [the original article was published in Oncology Letters 14: 8171‑8177, 2017; DOI: 10.3892/ol.2017.7184]

Related Articles

Journal Cover

March 2020
Volume 19 Issue 3

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
APA
Yong, M., Yu, T., Tian, S., Liu, S., Xu, J., Hu, J., & Hu, L. (2020). [Corrigendum] DR2 blocker thioridazine: A promising drug for ovarian cancer therapy. Oncology Letters, 19, 2072-2072. https://doi.org/10.3892/ol.2020.11285
MLA
Yong, M., Yu, T., Tian, S., Liu, S., Xu, J., Hu, J., Hu, L."[Corrigendum] DR2 blocker thioridazine: A promising drug for ovarian cancer therapy". Oncology Letters 19.3 (2020): 2072-2072.
Chicago
Yong, M., Yu, T., Tian, S., Liu, S., Xu, J., Hu, J., Hu, L."[Corrigendum] DR2 blocker thioridazine: A promising drug for ovarian cancer therapy". Oncology Letters 19, no. 3 (2020): 2072-2072. https://doi.org/10.3892/ol.2020.11285